TransCelerate BioPharma Inc. CEO Dr. Dalvir Gill shares results of their recent collaboration with the Society for Clinical Research Sites: The Shared Investigator Platform designed to reduce administrative burden by enabling investigative sites to interact with multiple clinical trial sponsors through a single point of access.
